LPL Financial’s Virtus Biotech ETF BBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$798K Buy
9,608
+1,024
+12% +$84.2K ﹤0.01% 4370
2025
Q4
$686K Buy
8,584
+2,346
+38% +$178K ﹤0.01% 4426
2025
Q3
$436K Buy
6,238
+2,015
+48% +$132K ﹤0.01% 4735
2025
Q2
$246K Sell
4,223
-490
-10% -$27.7K ﹤0.01% 4927
2025
Q1
$276K Sell
4,713
-1,929
-29% -$118K ﹤0.01% 4640
2024
Q4
$399K Buy
6,642
+1,484
+29% +$93.8K ﹤0.01% 4294
2024
Q3
$324K Buy
5,158
+330
+7% +$20.6K ﹤0.01% 4364
2024
Q2
$284K Sell
4,828
-300
-6% -$16.7K ﹤0.01% 4318
2024
Q1
$290K Buy
5,128
+257
+5% +$15K ﹤0.01% 4226
2023
Q4
$283K Sell
4,871
-354
-7% -$17.9K ﹤0.01% 4137
2023
Q3
$261K Buy
5,225
+390
+8% +$20.5K ﹤0.01% 4039
2023
Q2
$254K Sell
4,835
-608
-11% -$31.9K ﹤0.01% 3982
2023
Q1
$268K Buy
5,443
+722
+15% +$36.2K ﹤0.01% 3826
2022
Q4
$233K Buy
4,721
+15
+0.3% +$718 ﹤0.01% 3867
2022
Q3
$213K Buy
+4,706
New +$217K ﹤0.01% 3877
2022
Q1
Sell
-5,795
Closed -$283K 4197
2021
Q4
$283K Sell
5,795
-818
-12% -$40.7K ﹤0.01% 3716
2021
Q3
$337K Sell
6,613
-117
-2% -$6.03K ﹤0.01% 3559
2021
Q2
$359K Sell
6,730
-446
-6% -$23.5K ﹤0.01% 3446
2021
Q1
$376K Sell
7,176
-139
-2% -$7.75K ﹤0.01% 3283
2020
Q4
$389K Sell
7,315
-326
-4% -$16.7K ﹤0.01% 2975
2020
Q3
$364K Sell
7,641
-339
-4% -$15.8K ﹤0.01% 2752
2020
Q2
$378K Sell
7,980
-81
-1% -$3.62K ﹤0.01% 2651
2020
Q1
$302K Sell
8,061
-1,945
-19% -$80.4K ﹤0.01% 2501
2019
Q4
$436K Sell
10,006
-26
-0.3% -$1.04K ﹤0.01% 2488
2019
Q3
$360K Sell
10,032
-350
-3% -$13.4K ﹤0.01% 2532
2019
Q2
$426K Sell
10,382
-3,603
-26% -$148K ﹤0.01% 2393
2019
Q1
$627K Buy
13,985
+1,095
+8% +$45.9K ﹤0.01% 2021
2018
Q4
$450K Sell
12,890
-145
-1% -$5.52K ﹤0.01% 2120
2018
Q3
$592K Buy
13,035
+187
+1% +$8.36K ﹤0.01% 2101
2018
Q2
$564K Sell
12,848
-1,711
-12% -$72.6K ﹤0.01% 2095
2018
Q1
$601K Sell
14,559
-2,878
-17% -$121K ﹤0.01% 1988
2017
Q4
$707K Buy
17,437
+1,629
+10% +$65K ﹤0.01% 1770
2017
Q3
$657K Sell
15,808
-6,761
-30% -$270K ﹤0.01% 1735
2017
Q2
$895K Sell
22,569
-5,682
-20% -$212K ﹤0.01% 1446
2017
Q1
$1.05M Buy
28,251
+6,047
+27% +$221K 0.01% 1231
2016
Q4
$725K Buy
22,204
+5,055
+29% +$165K 0.01% 1431
2016
Q3
$567K Sell
17,149
-2,409
-12% -$74.4K 0.01% 1595
2016
Q2
$550K Sell
19,558
-15,022
-43% -$397K ﹤0.01% 1590
2016
Q1
$875K Sell
34,580
-9,182
-21% -$223K ﹤0.01% 1774
2015
Q4
$1.29M Buy
43,762
+26,584
+155% +$806K ﹤0.01% 1470
2015
Q3
$502K Sell
17,178
-1,341
-7% -$45.3K ﹤0.01% 1789
2015
Q2
$642K Buy
18,519
+4,975
+37% +$163K ﹤0.01% 1703
2015
Q1
$423K Buy
+13,544
New +$397K ﹤0.01% 1982

Other funds holding BBP

LPL Financial's BBP Position: Q1 2026 in Review

LPL Financial increased its Virtus Biotech ETF (BBP) stake by 12% in Q1 2026, buying an estimated $84.2K and bringing the position to 9,608 shares worth $798K. The position accounts for ﹤0.01% of the portfolio, ranked #4370.

LPL Financial first reported a position in BBP in Q1 2015 and has held it in 43 quarters since. The position peaked at $1.29M in Q4 2015. 26 funds tracked by Wall St. Rank hold BBP as of Q1 2026.

  • LPL Financial held 9,608 shares of Virtus Biotech ETF worth $798K as of Q1 2026.
  • LPL Financial bought 1,024 Virtus Biotech ETF shares in Q1 2026, an estimated $84.2K.
  • Virtus Biotech ETF made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #4370 holding.
  • LPL Financial first reported a position in Virtus Biotech ETF in Q1 2015 and has held it in 43 quarters since.
  • LPL Financial's Virtus Biotech ETF position peaked at $1.29M in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.